Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription


2 Am J Surg
1 Am J Surg Pathol
1 Ann Oncol
9 Ann Surg Oncol
2 Anticancer Res
3 BMC Cancer
1 Br J Cancer
2 Breast Cancer
1 Breast Cancer (Dove Med Press)
1 Breast Cancer Res
5 Breast Cancer Res Treat
1 Cancer
2 Cancer Lett
1 Clin Breast Cancer
2 Clin Cancer Res
1 Eur J Cancer
1 Genes Chromosomes Cancer
1 Int J Cancer
6 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
4 J Natl Cancer Inst
2 N Engl J Med
3 NPJ Breast Cancer
6 Oncogene
1 Oncol Rep
2 PLoS One
2 Radiology
1 Radiother Oncol

    Am J Surg

  1. JOHNSON L, Huppe A, Wagner JL, Amin AL, et al
    Is image-guided core needle biopsy of borderline axillary lymph nodes in breast cancer patients clinically helpful?
    Am J Surg. 2021 Jul 21. pii: S0002-9610(21)00402.
    >> Share

  2. MARKS CE, Thomas SM, Fayanju OM, DiLalla G, et al
    Metastatic breast cancer: Who benefits from surgery?
    Am J Surg. 2021 Jul 22. pii: S0002-9610(21)00398.
    >> Share

    Am J Surg Pathol

  3. LU S, Yakirevich E, Yang D, Xiao Y, et al
    Wnt Family Member 9b (Wnt9b) Is a New Sensitive and Specific Marker for Breast Cancer.
    Am J Surg Pathol. 2021 Jul 29. pii: 00000478-900000000-97158.
    >> Share

    Ann Oncol

  4. LOI S, Michiels S, Adams S, Loibl S, et al
    The journey of tumor infiltrating lymphocytes (TIL) as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition.
    Ann Oncol. 2021 Jul 23. pii: S0923-7534(21)02185.
    >> Share

    Ann Surg Oncol

  5. PAWLOSKI KR, Tadros AB, El-Tamer M
    ASO Author Reflections: Age Is an Important Determinant of Concordance Between 21-Gene Recurrence Scores in Multiple Ipsilateral Breast Carcinomas.
    Ann Surg Oncol. 2021;28:4263-4264.
    >> Share

  6. PARK KU, Birken S, Garvin J, Carson W 3rd, et al
    Practical Guide to Implementation Science for Surgical Oncologists: Case Study of Breast Cancer Short Stay Program.
    Ann Surg Oncol. 2021 Jul 23. pii: 10.1245/s10434-021-10479.
    >> Share

  7. WU ZY, Han J, Eom JS, Ahn SH, et al
    ASO Author Reflections: Do Shorter Tumor-to-Nipple Distances Compromise the Local Oncologic Safety of Nipple-Sparing Mastectomy?
    Ann Surg Oncol. 2021;28:4292-4293.
    >> Share

  8. CRIPPA S, Giannone F, Lena MS, Falconi M, et al
    ASO Author Reflections: R Status Is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma.
    Ann Surg Oncol. 2021;28:4613-4614.
    >> Share

  9. CHE BAKRI NA, Kwasnicki RM, Dhillon K, Khan N, et al
    Objective Assessment of Postoperative Morbidity After Breast Cancer Treatments with Wearable Activity Monitors: The "BRACELET" Study.
    Ann Surg Oncol. 2021 Jul 26. pii: 10.1245/s10434-021-10458.
    >> Share

  10. DILLON J, Thomas SM, Rosenberger LH, DiLalla G, et al
    Mortality in Older Patients with Breast Cancer Undergoing Breast Surgery: How Low is "Low Risk"?
    Ann Surg Oncol. 2021 Jul 26. pii: 10.1245/s10434-021-10502.
    >> Share

  11. SAUDER CAM, Li Q, Bold RJ, Ruddy KJ, et al
    ASO Visual Abstract: Secondary Breast Cancer Sociodemographic Characteristics and Survival by Age Group.
    Ann Surg Oncol. 2021 Jul 22. pii: 10.1245/s10434-021-10389.
    >> Share

  12. COCCO D, ElSherif A, Wright MD, Dempster MS, et al
    Invasive Lobular Breast Cancer: Data to Support Surgical Decision Making.
    Ann Surg Oncol. 2021 Jul 29. pii: 10.1245/s10434-021-10455.
    >> Share

  13. KAYALI M, Abi Jaoude J, Mohammed M, Khabsa J, et al
    Post-mastectomy Radiation Therapy in Triple-Negative Breast Cancer Patients: Analysis of the BEATRICE Trial.
    Ann Surg Oncol. 2021 Jul 29. pii: 10.1245/s10434-021-10511.
    >> Share

    Anticancer Res

  14. KIM H, Gim JA, Kim CY, Kim A, et al
    Intratumor Heterogeneity of Synchronous In Situ and Invasive Breast Carcinoma Revealed Using Multi-region Exome Sequencing.
    Anticancer Res. 2021;41:3779-3787.
    >> Share

  15. STELLER D, Simon R, VON Bialy R, Hakim SG, et al
    Impact of Zoledronic Acid and Denosumab Treatment on Growth Factor Concentration in Platelet Rich Fibrin of Patients With Osteolytic Bone Metastases.
    Anticancer Res. 2021;41:3917-3923.
    >> Share

    BMC Cancer

  16. JANG MK, Han J, Kim SH, Ko YH, et al
    Comparison of fatigue and fatigability correlates in Korean breast cancer survivors and differences in associations with anxiety, depression, sleep disturbance, and endocrine symptoms: a randomized controlled trial.
    BMC Cancer. 2021;21:855.
    >> Share

  17. TURKISTANI S, Sugita BM, Fadda P, Marchi R, et al
    A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer.
    BMC Cancer. 2021;21:861.
    >> Share

  18. WU W, Chen J, Deng H, Jin L, et al
    Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: a randomized pilot trial.
    BMC Cancer. 2021;21:862.
    >> Share


  19. MAGUIRE R, McCann L, Kotronoulas G, Kearney N, et al
    Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART).
    BMJ. 2021;374:n1647.
    >> Share

    Br J Cancer

  20. HICKEY TE, Dwyer AR, Tilley WD
    Arming androgen receptors to oppose oncogenic estrogen receptor activity in breast cancer.
    Br J Cancer. 2021 Jul 22. pii: 10.1038/s41416-021-01478.
    >> Share

    Breast Cancer

  21. TAKAHASHI S, Fukui T, Nomizu T, Kakugawa Y, et al
    TP53 signature diagnostic system using multiplex reverse transcription-polymerase chain reaction system enables prediction of prognosis of breast cancer patients.
    Breast Cancer. 2021 Jul 24. pii: 10.1007/s12282-021-01250.
    >> Share

  22. QIAO Y, van Londen GJ, Brufsky JW, Poppenberg JT, et al
    Perceived physical fatigability improves after an exercise intervention among breast cancer survivors: a randomized clinical trial.
    Breast Cancer. 2021 Jul 30. pii: 10.1007/s12282-021-01278.
    >> Share

    Breast Cancer (Dove Med Press)

  23. HADISAPUTRI YE, Habibah U, Abdullah FF, Halimah E, et al
    Antiproliferation Activity and Apoptotic Mechanism of Soursop (Annona muricata L.) Leaves Extract and Fractions on MCF7 Breast Cancer Cells.
    Breast Cancer (Dove Med Press). 2021;13:447-457.
    >> Share

    Breast Cancer Res

  24. MOHAMMED S, Shamseddine AA, Newcomb B, Chavez RS, et al
    Sublethal doxorubicin promotes migration and invasion of breast cancer cells: role of Src Family non-receptor tyrosine kinases.
    Breast Cancer Res. 2021;23:76.
    >> Share

    Breast Cancer Res Treat

  25. HANNA A, Balko JM
    Breast cancer resistance mechanisms: challenges to immunotherapy.
    Breast Cancer Res Treat. 2021 Jul 28. pii: 10.1007/s10549-021-06337.
    >> Share

  26. RUDDY KJ, Zheng Y, Tayob N, Hu J, et al
    Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
    Breast Cancer Res Treat. 2021;189:103-110.
    >> Share

  27. JERZAK KJ, Lipton N, Nofech-Mozes S, Boles D, et al
    Clinical outcomes and prognostic biomarkers among pregnant, post-partum and nulliparous women with breast cancer: a prospective cohort study.
    Breast Cancer Res Treat. 2021 Jul 27. pii: 10.1007/s10549-021-06327.
    >> Share

  28. EVANS DG, Howell SJ, Gandhi A, van Veen EM, et al
    Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women.
    Breast Cancer Res Treat. 2021 Jul 26. pii: 10.1007/s10549-021-06333.
    >> Share

  29. BALCH SM, Vaz-Luis I, Li T, Tayob N, et al
    A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast ca
    Breast Cancer Res Treat. 2021 Jul 24. pii: 10.1007/s10549-021-06329.
    >> Share


  30. ROBERTS SA, Gillespie TC, Shui AM, Brunelle CL, et al
    Weight loss does not decrease risk of breast cancer-related arm lymphedema.
    Cancer. 2021 Jul 27. doi: 10.1002/cncr.33819.
    >> Share

    Cancer Lett

  31. PENUGURTI V, Khumukcham SS, Padala C, Dwivedi A, et al
    HPIP protooncogene differentially regulates metabolic adaptation and cell fate in breast cancer cells under glucose stress via AMPK and RNF2 dependent pathways.
    Cancer Lett. 2021;518:243-255.
    >> Share

  32. MCGARRY DJ, Armstrong G, Castino G, Mason S, et al
    MICAL1 regulates actin cytoskeleton organization, directional cell migration and the growth of human breast cancer cells as orthotopic xenograft tumours.
    Cancer Lett. 2021 Jul 24. pii: S0304-3835(21)00371.
    >> Share

    Clin Breast Cancer

  33. HE X, Dai X, Ji J, Liu H, et al
    Nine-Year Median Follow-up of Ccardiotoxicity and Efficacy of Trastuzumab Concurrently With Anthracycline-Based and Anthracycline-Free Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer Patients.
    Clin Breast Cancer. 2021 May 24. pii: S1526-8209(21)00136.
    >> Share

    Clin Cancer Res

  34. TURNER NC, Balmana J, Poncet C, Goulioti T, et al
    Niraparib for advanced breast cancer with germline BRCA1 and BRCA2 mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO study.
    Clin Cancer Res. 2021 Jul 22. pii: 1078-0432.CCR-21-0310.
    >> Share

  35. GONZALEZ-ERICSSON PI, Wulfkhule JD, Gallagher RI, Sun X, et al
    Tumor-specific major histocompatibility-II expression predicts benefit to anti-PD-1/L1 therapy in patients with HER2-negative primary breast cancer.
    Clin Cancer Res. 2021 Jul 27. pii: 1078-0432.CCR-21-0607.
    >> Share

    Eur J Cancer

  36. LEFRERE H, Floris G, Schmidt MK, Neven P, et al
    Breast cancer diagnosed in the post-weaning period is indicative for a poor outcome.
    Eur J Cancer. 2021;155:13-24.
    >> Share

    Genes Chromosomes Cancer

  37. VAJEN B, Greiwe L, Schaffer V, Eilers M, et al
    MicroRNA-192-5p inhibits migration of triple negative breast cancer cells and directly regulates Rho GTPase Activating Protein 19.
    Genes Chromosomes Cancer. 2021 Jul 23. doi: 10.1002/gcc.22982.
    >> Share

    Int J Cancer

  38. LOFTUS PG, Watson L, Deedigan LM, Camarillo-Retamosa E, et al
    Targeting stromal cell Syndecan-2 reduces breast tumour growth, metastasis and limits immune evasion.
    Int J Cancer. 2021;148:1245-1259.
    >> Share

    Int J Radiat Oncol Biol Phys

  39. POLGAR C, Major T, Takacsi-Nagy Z, Fodor J, et al
    Breast-Conserving Surgery Followed by Partial or Whole Breast Irradiation: Twenty-Year Results of a Phase 3 Clinical Study.
    Int J Radiat Oncol Biol Phys. 2021;109:998-1006.
    >> Share

  40. JARVIS LA, Hachadorian RL, Jermyn M, Bruza P, et al
    Initial Clinical Experience of Cherenkov Imaging in External Beam Radiation Therapy Identifies Opportunities to Improve Treatment Delivery.
    Int J Radiat Oncol Biol Phys. 2021;109:1627-1637.
    >> Share

  41. KUMAR KA, Balazy KE, Gutkin PM, Jacobson CE, et al
    Association Between Patient Education Videos and Knowledge of Radiation Treatment.
    Int J Radiat Oncol Biol Phys. 2021;109:1165-1175.
    >> Share

  42. MENDEZ ROMERO A, Schillemans W, van Os R, Koppe F, et al
    The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:1377-1386.
    >> Share

  43. BOUTRUS RR, El Sherif S, Abdelazim Y, Bayomy M, et al
    Once Daily Versus Twice Daily External Beam Accelerated Partial Breast Irradiation: A Randomized Prospective Study.
    Int J Radiat Oncol Biol Phys. 2021;109:1296-1300.
    >> Share

  44. LAPEN K, Sabol C, Tin AL, Lynch K, et al
    Development and pilot implementation of a remote monitoring system for acute toxicity using electronic patient-reported outcomes (ePROs) for patients undergoing radiation therapy for breast cancer.
    Int J Radiat Oncol Biol Phys. 2021 Jul 24. pii: S0360-3016(21)02562.
    >> Share

    J Clin Oncol

  45. BURSTEIN HJ, Somerfield MR, Barton DL, Dorris A, et al
    Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline Update.
    J Clin Oncol. 2021 Jul 29:JCO2101392. doi: 10.1200/JCO.21.01392.
    >> Share

  46. MOY B, Rumble RB, Come SE, Davidson NE, et al
    Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update.
    J Clin Oncol. 2021 Jul 29:JCO2101374. doi: 10.1200/JCO.21.01374.
    >> Share

    J Natl Cancer Inst

  47. PAN IW, Oeffinger KC, Shih YT
    Cost-Sharing and Out-of-Pocket Cost for Women Who Received MRI for Breast Cancer Screening.
    J Natl Cancer Inst. 2021 Jul 28. pii: 6329641. doi: 10.1093.
    >> Share

  48. POORTMANS PM, Struikmans H, De Brouwer P, Weltens C, et al
    Side-ffects 15 Years after Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925.
    J Natl Cancer Inst. 2021 Jul 28. pii: 6329829. doi: 10.1093.
    >> Share

  49. WHITE J
    Benefit vs Harm of Internal Mammary Node Irradiation for Node-Positive Breast Cancer.
    J Natl Cancer Inst. 2021 Jul 28. pii: 6329830. doi: 10.1093.
    >> Share

  50. YEH JM, Lowry KP, Schechter CB, Diller LR, et al
    Breast Cancer Screening Among Childhood Cancer Survivors Treated Without Chest Radiation: Clinical Benefits and Cost-Effectiveness.
    J Natl Cancer Inst. 2021 Jul 29. pii: 6330765. doi: 10.1093.
    >> Share

    N Engl J Med

  51. GNANT M, Fitzal F, Rinnerthaler G, Steger GG, et al
    Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
    N Engl J Med. 2021;385:395-405.
    >> Share

    Extended Aromatase Inhibitors in Hormone-Receptor-Positive Breast Cancer.
    N Engl J Med. 2021;385:462-463.
    >> Share

    NPJ Breast Cancer

  53. CHANG MC, Eslami Z, Ennis M, Goodwin PJ, et al
    Crown-like structures in breast adipose tissue of breast cancer patients: associations with CD68 expression, obesity, metabolic factors and prognosis.
    NPJ Breast Cancer. 2021;7:97.
    >> Share

  54. POORVU PD, Hu J, Zheng Y, Gelber SI, et al
    Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer.
    NPJ Breast Cancer. 2021;7:99.
    >> Share

  55. BAYANI J, Poncet C, Crozier C, Neven A, et al
    Evaluation of multiple transcriptomic gene risk signatures in male breast cancer.
    NPJ Breast Cancer. 2021;7:98.
    >> Share


  56. CHEN D, Parker TM, Bhat-Nakshatri P, Chu X, et al
    Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression.
    Oncogene. 2021;40:1332-1346.
    >> Share

  57. WHATELY KM, Voronkova MA, Maskey A, Gandhi J, et al
    Nuclear Aurora-A kinase-induced hypoxia signaling drives early dissemination and metastasis in breast cancer: implications for detection of metastatic tumors.
    Oncogene. 2021 Jul 29. pii: 10.1038/s41388-021-01969.
    >> Share

  58. AL-AKHRASS H, Conway JRW, Poulsen ASA, Paatero I, et al
    A feed-forward loop between SorLA and HER3 determines heregulin response and neratinib resistance.
    Oncogene. 2021;40:1300-1317.
    >> Share

  59. GU G, Tian L, Herzog SK, Rechoum Y, et al
    Hormonal modulation of ESR1 mutant metastasis.
    Oncogene. 2021;40:997-1011.
    >> Share

  60. SETO-TETSUO F, Arioka M, Miura K, Inoue T, et al
    DIF-1 inhibits growth and metastasis of triple-negative breast cancer through AMPK-mediated inhibition of the mTORC1-S6K signaling pathway.
    Oncogene. 2021 Jul 24. pii: 10.1038/s41388-021-01958.
    >> Share

  61. VARONE E, Decio A, Chernorudskiy A, Minoli L, et al
    The ER stress response mediator ERO1 triggers cancer metastasis by favoring the angiogenic switch in hypoxic conditions.
    Oncogene. 2021;40:1721-1736.
    >> Share

    Oncol Rep

  62. ZONG B, Sun L, Peng Y, Wang Y, et al
    [Corrigendum] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance.
    Oncol Rep. 2021;46.
    >> Share

    PLoS One

  63. AHMED F, Adnan M, Malik A, Tariq S, et al
    Perception of breast cancer risk factors: Dysregulation of TGF-beta/miRNA axis in Pakistani females.
    PLoS One. 2021;16:e0255243.
    >> Share

  64. KIM JJ, Liang W, Kang CC, Pegram MD, et al
    Single-cell immunoblotting resolves estrogen receptor-alpha isoforms in breast cancer.
    PLoS One. 2021;16:e0254783.
    >> Share


  65. MOY L, Gao Y
    Supplemental MRI in Extremely Dense Breasts: Sharp Reduction in False-Positive Rate in the Second Screening Round of the DENSE Trial.
    Radiology. 2021 Mar 16:210265. doi: 10.1148/radiol.2021210265.
    >> Share

  66. FEIG SA
    Influence of Patient Participation on Decreased Mortality from Screening Mammography.
    Radiology. 2021 Mar 30:210226. doi: 10.1148/radiol.2021210226.
    >> Share

    Radiother Oncol

  67. KAIDAR-PERSON O, Offersen BV, Boersma L, Meattini I, et al
    Tricks and tips for target volume definition and delineation in breast cancer: lessons learned from ESTRO breast courses.
    Radiother Oncol. 2021 Jul 21. pii: S0167-8140(21)06658.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016